About Scribe Therapeutics Inc
Scribe Therapeutics is pioneering highly engineered CRISPR technologies designed to reshape the treatment of disease by enabling earlier intervention, improved outcomes, and longer, healthier lives.
Scribe Therapeutics Inc (SCTX) Stock Score & Signals
Scribe Therapeutics Inc (SCTX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 20 out of 100.
2BB score and signals
Scribe Therapeutics Inc’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 5 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 8 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 88 | Very High (provisional) |
Company facts
| Founded | 2017 |
| Employees | 82 |
| 52-week range | $13.50 – $39.60 |